Journal profile · Medicine-Neurology (clinical)
Nervno-Myshechnye Bolezni
ISSN 2222-8721 · eISSN 2413-0443 · ABV-press Publishing house, LLC · Russian Federation
Nervno-Myshechnye Bolezni: fully open access; APC charged, amount not published; review about 8 weeks (community reports); 26 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Nervno-Myshechnye Bolezni is published by ABV-press Publishing house, LLC. By OpenAlex counts of its recent articles, its largest topics are Hereditary Neurological Disorders, Peripheral Neuropathies and Disorders and Neurogenetic and Muscular Disorders Research, together about 30% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The principal objective of the "Neuromuscular Diseases" journal is publication of state-of-art information about scientific clinical studies, diagnostics, and treatment of neurological diseases. "Neuromuscular Diseases" is a peer-reviewed journal, and members of its editorial board are major professionals in Russia and the CIS countries that have deserved authority not only in our country but abroad as well. Besides, leading scientists of Europe and the USA regularly cooperate with the journal. The journal regularly publishes reviews of modern literature references, proprietary clinical observations, lectures, original articles, results of research protocols in various areas of neuromuscular pathology - clinical presentation, diagnostics, medication, surgical and non-drug therapies, modern trends in drug rehabilitation, and recent drug developments. Due to international cooperation, the journal contains the newest therapeutic and diagnostic approaches to monitoring of patients with neuromuscular pathology. The journal reviews social aspects of monitoring, algorithms of social aid and adaptation of this category of patients. The journal contains the information about outcomes of conferences, symposia, meetings, training programs for neuromuscular diseases; reports on the work of Russian and foreign specialized neurological wards.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Neurology (clinical)
Editorial board by country: none in mainland China; most named Russia 24, France 1, Netherlands 1 (26 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hereditary Neurological DisordersNeuroscience11.7%
- Peripheral Neuropathies and DisordersMedicine9.2%
- Neurogenetic and Muscular Disorders ResearchMedicine9.2%
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology8.4%
- Peripheral Nerve DisordersMedicine8.4%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology7.9%
- Amyotrophic Lateral Sclerosis ResearchMedicine5.2%
- Lysosomal Storage Disorders ResearchMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Neurology (clinical) | Q4 | 338/403 | — |
| Neurology | Q4 | 173/201 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.8LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 17OpenAlex ·
- 2-year mean citedness
- 0.64OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 363 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 20 | 88 |
| 2025 | 26 | 26 | 156 |
| 2024 | 37 | 37 | 127 |
| 2023 | 25 | 25 | 84 |
| 2022 | 29 | 29 | 56 |
| 2021 | 28 | 28 | 59 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- Numbered, in order of citation
Article types accepted4
- clinical casesClinical cases – no more than 8 pages.Length not stated
- research articlesResearch articles – not greater than 12 pages (larger volume is allowed on an individual agreement with the editorial board).Length not stated
- review articlesReview articles – up to 20 pages.Length not stated
- short reports and editorialsShort reports and editorials – 3 pages.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Peer review, Plagiarism, Preprints
- Authorship 6.2.1 Authorship and authors’ contributions
According to the recommendations of the ICMJE, the right to be referred as the author have those persons who made significant contribution to the conception and design of the study or in the data analysis and its interpretation, actively participated in drafting the article or making fundamental changes, participated in the final approval of the version that is to be published and ready to take re…
Source ↗Publisher website ·- Conflicts of interest 6.2.2 Conflict of interest
At the end of the article you must specify conflicts of interest for all authors. Conflict of interest implies the existence of any relations and/or personal interest that potentially can affect results, interpretation of data, its objective perception, such as financial relations and cooperation with any organizations (e.g., receipt of fees, educational grants, participation in expert councils, m…
Source ↗Publisher website ·- License & copyright Copyright Notice
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, addition…
Source ↗Publisher website ·- Peer review Peer Review Process
Review of the articles for publication takes at least 8 weeks in order of receipt by the editor. Model summary
A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of "Neuromuscular Diseases". This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer. Members of the editorial board and leading Russian and international experts in corresponding areas of li…
Source ↗Publisher website ·- Plagiarism Borrowing and Plagiarism
Previously published articles will be discarded. Model summary
Publication of works containing plagiarism of text, ideas, data is prohibited. Authors should submit fully original works. Results of other authors’ work should be appropriately cited or quoted; quotations of a text previously published should be written as the direct speech with the obligatory indication of the original source. The editorial board of the journal checks the material using plagiari…
Source ↗Publisher website ·- Preprints Preprint and Postprint Policy
Prior to acceptance and publication in "Neuromuscular Diseases", authors may make their submissions available as preprints on personal or public websites. As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in "Neuromuscular Diseases" we suggest that the link to the artic…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- ABV-press Publishing house, LLC
- Country or region
- Russian Federation
- Language
- Russian
- ISSN
- 2222-8721
- Electronic ISSN
- 2413-0443
- Society / sponsor
- Regional Public Organization “Association of Neuromuscular Disorders Specialists”
- Latest issue on the website
- Volume 16, Issue 1 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Nervno-Myshechnye Bolezni
How long does peer review take at Nervno-Myshechnye Bolezni?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Nervno-Myshechnye Bolezni?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Nervno-Myshechnye Bolezni based?
Of the 26 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (24), France (1) and Netherlands (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Nervno-Myshechnye Bolezni?
According to LetPub and DOAJ records, Nervno-Myshechnye Bolezni is indexed in Scopus.
Is Nervno-Myshechnye Bolezni open access, and what is the APC?
Nervno-Myshechnye Bolezni is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .